What is the current recommendation for management of syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Recommendations for Syphilis Management

Benzathine penicillin G remains the definitive treatment for all stages of syphilis, with dosing and duration determined by disease stage—no alternative has proven superior efficacy or safety. 1

Primary and Secondary Syphilis

Administer benzathine penicillin G 2.4 million units intramuscularly as a single dose. 1, 2 This regimen achieves 90–100% treatment success based on decades of clinical experience. 1, 3

Follow-Up Protocol

  • Perform quantitative nontreponemal tests (RPR or VDRL) at 3,6, and 12 months after treatment. 1
  • Expect a fourfold decline in titer within 6 months for early syphilis. 1
  • Treatment failure is defined as: persistent symptoms, sustained fourfold titer increase, or failure of titers to decline fourfold within 6 months. 1

Early Latent Syphilis (≤1 Year Duration)

Give benzathine penicillin G 2.4 million units IM as a single dose. 1 Early latent syphilis is defined by documented seroconversion within the past year, fourfold titer increase, recent symptoms of primary/secondary syphilis, or a sex partner with confirmed early syphilis. 1

Late Latent Syphilis and Tertiary Syphilis (>1 Year or Unknown Duration)

Administer benzathine penicillin G 7.2 million units total as three weekly doses of 2.4 million units IM each. 1, 4

Critical Pre-Treatment Step

Perform CSF examination before treatment if any of the following are present: 1, 4

  • Neurologic signs or symptoms (cognitive dysfunction, motor/sensory deficits, cranial nerve palsies, meningismus)
  • Ophthalmic involvement (uveitis, neuroretinitis, optic neuritis)
  • Evidence of active tertiary disease (cardiovascular syphilis, gummas)
  • Treatment failure
  • HIV infection with late latent syphilis
  • Nontreponemal titer ≥1:32

If neurosyphilis is identified, the tertiary regimen is inadequate—switch to the neurosyphilis protocol immediately. 4

Follow-Up for Late Disease

  • Repeat quantitative nontreponemal tests at 6,12, and 24 months. 1, 4
  • Expect fourfold titer decline within 12–24 months. 1, 4

Neurosyphilis

Administer aqueous crystalline penicillin G 18–24 million units IV daily (given as 3–4 million units every 4 hours or continuous infusion) for 10–14 days. 1, 4

Alternative Outpatient Regimen (Only if Compliance Assured)

Procaine penicillin 2.4 million units IM once daily PLUS probenecid 500 mg orally four times daily for 10–14 days. 1

Critical caveat: Procaine penicillin without probenecid is completely inadequate because it fails to achieve therapeutic CSF levels. 1 Never use this regimen in patients with sulfonamide allergy due to cross-reactivity with probenecid. 1

Neurosyphilis Follow-Up

  • If initial CSF pleocytosis was present, repeat lumbar puncture every 6 months until WBC count normalizes. 1
  • Retreat if: CSF cell count has not decreased after 6 months OR CSF remains abnormal after 2 years. 1

Penicillin-Allergic Patients (Non-Pregnant)

Early Syphilis (Primary, Secondary, Early Latent)

Doxycycline 100 mg orally twice daily for 14 days is the preferred alternative. 1 Tetracycline 500 mg orally four times daily for 14 days is acceptable but doxycycline has better adherence. 1

Ceftriaxone 1 gram IM or IV daily for 10–14 days may be considered based on moderate-quality evidence from one randomized trial showing comparable efficacy to benzathine penicillin. 1, 5 However, patients with severe penicillin allergy may also react to ceftriaxone due to beta-lactam cross-reactivity. 1

Late Latent Syphilis (Non-Pregnant)

Doxycycline 100 mg orally twice daily for 28 days. 1 Tetracycline 500 mg orally four times daily for 28 days is an alternative. 1

Mandatory before any non-penicillin regimen: Perform CSF examination to exclude neurosyphilis, as oral regimens are inadequate for CNS disease. 1

Neurosyphilis in Penicillin-Allergic Patients

Penicillin desensitization followed by standard IV penicillin is strongly preferred. 1 If desensitization is absolutely not feasible, ceftriaxone 2 grams IV daily for 10–14 days may be considered, but evidence is extremely limited. 1

Pregnancy

All pregnant patients with syphilis MUST receive penicillin—no exceptions. 1, 4 Penicillin is the only therapy with documented efficacy for preventing congenital syphilis and treating fetal infection. 1, 2

Penicillin-Allergic Pregnant Patients

Mandatory penicillin desensitization followed by stage-appropriate penicillin therapy. 1, 4 Tetracycline, doxycycline, erythromycin, azithromycin, and ceftriaxone are absolutely contraindicated—erythromycin does not reliably cure fetal infection. 1

Additional Pregnancy Considerations

  • Some experts recommend a second dose of benzathine penicillin 2.4 million units IM one week after the initial dose for women with primary, secondary, or early latent syphilis. 1
  • Jarisch-Herxheimer reaction in the second half of pregnancy can precipitate preterm labor or fetal distress—advise women to seek immediate care if they notice contractions or decreased fetal movement. 1
  • Screen all pregnant women at first prenatal visit, at 28 weeks, and at delivery. 1
  • If a pregnant woman misses any weekly dose, restart the entire three-dose sequence—no partial courses are acceptable. 1

HIV-Infected Patients

HIV-infected patients receive the same penicillin regimens as HIV-negative patients for all disease stages. 6, 1 However, closer monitoring is essential due to higher rates of atypical serologic responses and treatment failure. 6

Enhanced Follow-Up for HIV-Positive Patients

Evaluate clinically and serologically at 3,6,9,12, and 24 months after therapy. 6, 1

Special Considerations

  • For late latent syphilis with HIV infection, consider CSF examination before treatment to exclude neurosyphilis. 6
  • Limited data suggest no benefit to multiple doses of benzathine penicillin for early syphilis in HIV-infected patients compared to a single dose. 1
  • Penicillin-allergic HIV-infected patients should undergo desensitization and receive penicillin. 6, 1

Management of Sexual Partners

Presumptively treat all sexual partners exposed within 90 days before diagnosis of primary, secondary, or early latent syphilis—even if seronegative. 1 Give benzathine penicillin G 2.4 million units IM as a single dose. 1

Time windows for presumptive treatment: 1

  • Primary syphilis: 3 months plus duration of symptoms
  • Secondary syphilis: 6 months plus duration of symptoms
  • Early latent syphilis: 1 year

Partners exposed >90 days prior should also be treated presumptively when serologic results are unavailable and reliable follow-up cannot be ensured. 1

Critical Pitfalls to Avoid

Never use oral penicillin preparations for syphilis—they are completely ineffective. 1

Never use azithromycin in the United States due to widespread macrolide resistance and documented treatment failures. 1, 7

Never switch between RPR and VDRL when monitoring serologic response—results cannot be directly compared. 1

Never skip CSF examination before treating late latent or tertiary syphilis in high-risk patients—you may miss neurosyphilis requiring different treatment. 4

Never use procaine penicillin without probenecid for neurosyphilis—CSF levels will be inadequate. 1

Do not rely on treponemal test titers to assess treatment response—they correlate poorly with disease activity. 1

Jarisch-Herxheimer Reaction

Warn all patients about the Jarisch-Herxheimer reaction—an acute febrile reaction with headache, myalgia, and other symptoms occurring within 24 hours of treatment, most common in early syphilis. 1 No proven preventive measures exist; antipyretics may provide symptomatic relief. 1

HIV Testing

Test all patients diagnosed with syphilis for HIV at the time of diagnosis. 1, 2

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Treatment for Stage 3 (Tertiary) Syphilis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Syphilis: Re-emergence of an old foe.

Microbial cell (Graz, Austria), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.